Acasti Pharma Inc. Annual report pursuant to Section 13 and 15(d)

Note 7 - Government Assistance (Tables)

12 Months Ended

Mar. 31, 2020

	March 31, 2020		March 31, 2019

	$		$
Investment tax credit		182		652
Government grant		27		-
Total government assistance		209		652

	March 31, 2020
	Federal		Provincial
		$		$
Tax losses carried forward
2028		508		508
2029		1,157		1,152
2030		1,473		1,467
2031		1,609		1,594
2032		1,318		1,298
2033		2,559		2,559
2034		3,268		3,171
2035		3,907		3,907
2036		5,749		5,661
2037		356		352
2038		12,331		12,281
2039		28,811		28,773
2040		20,311		20,311
		83,357		83,034

Research and development expenses, without time limitation		16,698		17,732

Tax credit carry forwards		2,468		-

Other deductible temporary differences, without time limitation		5,282		5,282